← All patents

US10722487B2

Glutaminase inhibitor therapy

University of Texas System

Abstract

Disclosed herein are methods of treating a tumor or cancer in a subject whose tumor or cancer cells express low levels of asparagine synthetase (ASNS), and compounds and compositions useful in such treatment. Also disclosed herein are methods of evaluating whether to administer a compound that …

University
University of Texas System
Assignee
Board Of Regents, The University Of Texas System
Inventor
Timothy Heffernan
Priority date
October 18, 2017
Filing date
October 18, 2018
Grant date
July 28, 2020
Publication date
July 28, 2020
Language
en
Metadata fetched
August 29, 2026 00:26